EUVIMEDEUVIMED entdecken
Crossref

An AI-Guided Biparatopic DLL3-Targeting ADC Demonstrates Enhanced Preclinical Efficacy

Y. Wu, Y. He, S. Jiang, J. Tian, Y. Shang, D. Liu, Z. Chen, R. Shen, L. Tian, H. Ran, J. Peng, Z. Zhu

European Journal of Cancer · 2026-11 · 248 · 117503

DOI: 10.1016/j.ejca.2026.117503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von Y. Wu und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Wu, Y., He, Y., Jiang, S., Tian, J., Shang, Y., Liu, D., Chen, Z., Shen, R., Tian, L., Ran, H., Peng, J., & Zhu, Z. (2026). An AI-Guided Biparatopic DLL3-Targeting ADC Demonstrates Enhanced Preclinical Efficacy. European Journal of Cancer, 248, 117503. https://doi.org/10.1016/j.ejca.2026.117503

Vancouver

Wu Y, He Y, Jiang S, Tian J, Shang Y, Liu D, et al. An AI-Guided Biparatopic DLL3-Targeting ADC Demonstrates Enhanced Preclinical Efficacy. European Journal of Cancer. 2026;248:117503. doi:10.1016/j.ejca.2026.117503

BibTeX
@article{Wu2026,
  author = {Wu, Y. and He, Y. and Jiang, S. and Tian, J. and Shang, Y. and Liu, D. and Chen, Z. and Shen, R. and Tian, L. and Ran, H. and Peng, J. and Zhu, Z.},
  title = {An AI-Guided Biparatopic DLL3-Targeting ADC Demonstrates Enhanced Preclinical Efficacy},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {248},
  pages = {117503},
  doi = {10.1016/j.ejca.2026.117503}
}
Kostenlos starten →